Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.
暂无分享,去创建一个
G. Reboux | L. Millon | E. Deconinck | E Deconinck | G Reboux | L Millon | S Rocchi | F Larosa | E Scherer | E Daguindeau | A Berceanu | A-P Bellanger | A. Bellanger | A. Berceanu | F. Larosa | S. Rocchi | E. Scherer | E. Daguindeau
[1] V. Raina,et al. Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation , 2013, Indian Journal of Medical and Paediatric Oncology.
[2] T. Peláez,et al. Demolition of a hospital building by controlled explosion: the impact on filamentous fungal load in internal and external air. , 2002, The Journal of hospital infection.
[3] M. Rupp,et al. Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients. , 2008, The Journal of hospital infection.
[4] M. Netea,et al. Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis , 2012, Journal of Clinical Microbiology.
[5] B. Hargadon,et al. Isolation of Aspergillus fumigatus from sputum is associated with elevated airborne levels in homes of patients with asthma. , 2013, Indoor air.
[6] F. Grenouillet,et al. Ribosomal and Mitochondrial DNA Target for Real-Time PCR Diagnosis of Invasive Aspergillosis , 2011, Journal of Clinical Microbiology.
[7] G. Reboux,et al. qPCR standard operating procedure for measuring microorganisms in dust from dwellings in large cohort studies. , 2014, The Science of the total environment.
[8] L. Pagano,et al. Design and Methods , 2022 .
[9] E. van Wijngaerden,et al. Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] C. Viscoli,et al. Bacterial infection prevention after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.
[11] C. Maslo,et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.
[12] F. Derouin,et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. , 2001, The Journal of hospital infection.
[13] A. Voss,et al. Hospital sources of Aspergillus species: New routes of transmission? , 2001 .
[14] V. Aquino,et al. The indoor air as a potential determinant of the frequency of invasive aspergillosis in the intensive care , 2013, Mycoses.
[15] B. Segal,et al. Infection Control Measures to Prevent Invasive Mould Diseases in Hematopoietic Stem Cell Transplant Recipients , 2009, Mycopathologia.
[16] A. Warris,et al. Point-of-use filtration method for the prevention of fungal contamination of hospital water. , 2010, The Journal of hospital infection.
[17] Michael Boeckh,et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] D. Kontoyiannis,et al. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success , 2011, Bone Marrow Transplantation.
[19] J. Wingard,et al. Fungal infection prevention after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.
[20] D. Kontoyiannis,et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). , 2006, Haematologica.
[21] K. Marr,et al. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] E. Anaissie,et al. Factors associated with mortality in transplant patients with invasive aspergillosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] P. Moreau,et al. [Invasive aspergillosis in intensive care]. , 1995, Annales francaises d'anesthesie et de reanimation.
[24] A. Soubani,et al. Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.
[25] C. Viscoli,et al. Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management? , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Tiina Reponen,et al. Everyday activities and variation of fungal spore concentrations in indoor air , 1993 .
[27] M. Boeckh,et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.
[28] L. Millon,et al. Appréciation quantitative du risque fongique en cas de travaux en établissements de santé : propositions d’indicateurs d’impact des mesures de gestion du risque infectieux fongique , 2012 .
[29] P. Vanhems,et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] Gabriel Reboux,et al. Characteristics of dwellings contaminated by moulds. , 2008, Journal of environmental monitoring : JEM.
[31] B. Lebeau,et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). , 2006, The Journal of hospital infection.
[32] L. Millon,et al. [Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection]. , 2012, Journal de mycologie medicale.
[33] L. Pagano,et al. Treatment Strategies for Invasive Aspergillosis in Neutropenic Patients: Voriconazole or Liposomal Amphotericin-B? , 2011, Journal of chemotherapy.
[34] R. Piarroux,et al. Indoor mold concentration in Eastern France. , 2009, Indoor air.
[35] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] D. Kontoyiannis,et al. Occupation, Lifestyle, Diet, and Invasive Fungal Infections , 2008, Infection.
[37] A. Streifel,et al. Ten-year air sample analysis of Aspergillus prevalence in a university hospital. , 2007, The Journal of hospital infection.
[38] L. Pagano,et al. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. , 2011, The Journal of antimicrobial chemotherapy.